Sydney Abbott, JD

Because of failed debt negotiation talks back in 2011, on April 1, 2013, an automatic 2% reduction in payment took place across the board on all claims submitted for Medicare reimbursement. Read More ›

What a Continually Divided Congress Means for Community Oncology

By Sydney Abbott, JD

April 2013, Vol 3, No 3

The Association of Community Cancer Centers (ACCC) held its 39th Annual National Meeting for members March 6-8, 2013. The day after ACCC members went to Capitol Hill to participate in nearly 120 scheduled meetings with members of Congress, a panel of 3 policy specialists discussed the current political climate and the probability of oncology-related legislation moving forward in a continually divided Congress. Read More ›

Second Circuit Okays Off-Label Promotion: What Will Be the Impact on Provider/Rep Interaction?

By Sydney Abbott, JD

March 2013, Vol 3, No 2

Since 2004, under the False Claims Act, whistleblowers have fueled numerous federal investigations into fraudulent claims for reimbursement from federal programs, such as Medicare, that violated the Food, Drug, & Cosmetic (FD&C) Act. Read More ›

Essential Health Benefits: Will the Minimum Coverage Plan Cover Cancer Patients?

By Sydney Abbott, JD

February 2013, Vol 3, No 1

Beginning in 2014, state health insurance exchanges will offer consumers a more organized and competitive market for buying health insurance. Essential health benefits (EHBs) are the minimum benefits that must be covered by any insurance policy, known as a qualified health plan, offered on the state health insurance exchanges. Read More ›

The Affordable Care Act Will Change Medicare: The Independent Payment Advisory Board

By Sydney Abbott, JD

November 2012, Vol 2, No 6

Affordable Care Act

The Patient Protection and Affordable Care Act (ACA) of 2010 created many important reforms in healthcare. Many of the ACA’s provisions are very popular, such as the ability of parents to keep children on their health insurance plans until age 26 years and the elimination of insurance denials for pre-existing conditions. Other provisions are not as popular. Read More ›

Medicare Cuts: What’s Coming for Community Oncology

By Sydney Abbott, JD

September 2012, Vol 2, No 5

By Sydney Abbott, JD

July 2012, Vol 2, No 4

Affordable Care Act

Cancer Drug Shortages

By Sydney Abbott, JD

May 2012, Vol 2, No 3

Every day, increasing numbers of patients learn that a chemo - therapy has been developed that could save their lives, but the drug they need is unavailable, because no one is manufacturing it. Read More ›

Oral Parity: Taking It to the Next Level - March 2012

By Sydney Abbott, JD

March 2012, Vol 2, No 2

Imagine that you are a patient who has been recently diagnosed with cancer. While you are still recovering from a difficult surgery to remove the tumor, your oncologist advises you it is time to begin chemotherapy. Read More ›

ACO Final Rule: Enough to Entice the Oncology Team?

By Sydney Abbott, JD

February 2012, Vol 2, No 1

The result of the November 17, 2011, hyperpartisan Congress is policymaking stuck firmly in division and gridlock. Many healthcare issues remain in contention, including key components of the Patient Protection and Affordable Care Act (ACA). Read More ›

Will the Sunshine Act Affect Physician–Pharmaceutical Interaction?

By Sydney Abbott, JD

December 2011, Vol 1, No 4

We are just now beginning to see some of the lesser known pieces of the 2010 Patient Protection and Affordable Care Act, such as the Federal Physician Sunshine Act, which is designed to illuminate the relationship between physicians and manufacturers. Read More ›

Hurdles to Appropriate Reimbursement

By Sydney Abbott, JD

October 2011, Vol 1, No 3

Reimbursement

This has proven to be a difficult year for reimbursement for community cancer care providers. Al - though there are many hurdles to appropriate reimbursement, 3 issues are hanging fire in Congress this year. Read More ›

Sydney Abbott, JD

Top Trending Articles

CONNECT